Literature DB >> 34043111

Autologous Transplantation for Parkinson's Disease Patients: Feasibility and Challenge.

Qi Zhang1,2, Yanlin Wang1, Yukai Wang3,4,5,6, Han Liu1, Huifang Sun1,2, Zhuoya Wang1, Changhe Shi1, Jing Yang1, Yuming Xu7.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34043111      PMCID： PMC8275752          DOI： 10.1007/s12264-021-00712-w

Source DB:  PubMed          Journal:  Neurosci Bull        ISSN： 1995-8218            Impact factor:   5.271


× No keyword cloud information.
  10 in total

Review 1.  Biomarkers for Parkinson's Disease: How Good Are They?

Authors:  Tianbai Li; Weidong Le
Journal:  Neurosci Bull       Date:  2019-10-23       Impact factor: 5.203

Review 2.  Neuroprotective Effects of Brain-Gut Peptides: A Potential Therapy for Parkinson's Disease.

Authors:  Dong Dong; Junxia Xie; Jun Wang
Journal:  Neurosci Bull       Date:  2019-07-08       Impact factor: 5.203

3.  Personalized iPSC-Derived Dopamine Progenitor Cells for Parkinson's Disease.

Authors:  Jeffrey S Schweitzer; Bin Song; Todd M Herrington; Tae-Yoon Park; Nayeon Lee; Sanghyeok Ko; Jeha Jeon; Young Cha; Kyungsang Kim; Quanzheng Li; Claire Henchcliffe; Michael Kaplitt; Carolyn Neff; Otto Rapalino; Hyemyung Seo; In-Hee Lee; Jisun Kim; Taewoo Kim; Gregory A Petsko; Jerome Ritz; Bruce M Cohen; Sek-Won Kong; Pierre Leblanc; Bob S Carter; Kwang-Soo Kim
Journal:  N Engl J Med       Date:  2020-05-14       Impact factor: 91.245

4.  Human iPS cell-derived dopaminergic neurons function in a primate Parkinson's disease model.

Authors:  Tetsuhiro Kikuchi; Asuka Morizane; Daisuke Doi; Hiroaki Magotani; Hirotaka Onoe; Takuya Hayashi; Hiroshi Mizuma; Sayuki Takara; Ryosuke Takahashi; Haruhisa Inoue; Satoshi Morita; Michio Yamamoto; Keisuke Okita; Masato Nakagawa; Malin Parmar; Jun Takahashi
Journal:  Nature       Date:  2017-08-30       Impact factor: 49.962

5.  Induction of pluripotent stem cells from adult human fibroblasts by defined factors.

Authors:  Kazutoshi Takahashi; Koji Tanabe; Mari Ohnuki; Megumi Narita; Tomoko Ichisaka; Kiichiro Tomoda; Shinya Yamanaka
Journal:  Cell       Date:  2007-11-30       Impact factor: 41.582

6.  Balancing Expectations for Success in Stem Cell-Based Clinical Trials for Parkinson's Disease.

Authors:  Olle Lindvall
Journal:  Cell Stem Cell       Date:  2020-10-01       Impact factor: 24.633

Review 7.  Diagnosis and Treatment of Parkinson Disease: A Review.

Authors:  Melissa J Armstrong; Michael S Okun
Journal:  JAMA       Date:  2020-02-11       Impact factor: 56.272

8.  Human autologous iPSC-derived dopaminergic progenitors restore motor function in Parkinson's disease models.

Authors:  Bin Song; Young Cha; Sanghyeok Ko; Jeha Jeon; Nayeon Lee; Hyemyung Seo; Kyung-Joon Park; In-Hee Lee; Claudia Lopes; Melissa Feitosa; María José Luna; Jin Hyuk Jung; Jisun Kim; Dabin Hwang; Bruce M Cohen; Martin H Teicher; Pierre Leblanc; Bob S Carter; Jeffrey H Kordower; Vadim Y Bolshakov; Sek Won Kong; Jeffrey S Schweitzer; Kwang-Soo Kim
Journal:  J Clin Invest       Date:  2020-02-03       Impact factor: 14.808

9.  Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.

Authors: 
Journal:  Lancet Neurol       Date:  2019-03-14       Impact factor: 44.182

10.  Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease.

Authors:  Sonja Kriks; Jae-Won Shim; Jinghua Piao; Yosif M Ganat; Dustin R Wakeman; Zhong Xie; Luis Carrillo-Reid; Gordon Auyeung; Chris Antonacci; Amanda Buch; Lichuan Yang; M Flint Beal; D James Surmeier; Jeffrey H Kordower; Viviane Tabar; Lorenz Studer
Journal:  Nature       Date:  2011-11-06       Impact factor: 49.962
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.